| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588420 | Metabolism | 2017 | 10 Pages |
Abstract
NAFLD rather than advanced hepatic fibrosis is independently associated with increased prevalence of chylomicrons + very low-density lipoproteins (VLDL) remnants, VLDL, LDL and VLDL + LDL dyslipoproteinemias. ApoB dyslipoproteinemias may contribute to increased CVD risk associated with NAFLD.
Keywords
EGFRGGTT2DMapoBFLIVLDLApoA-INFsHDLNAFLDALTASTAspartate aminotransferaseAlanine aminotransferaseApolipoprotein A-IApolipoprotein BNon-alcoholic steatohepatitiscardiovascular diseaseCardiovascular diseasesnon-alcoholic fatty liver diseaseTriglyceridesType 2 diabetes mellitusCVDMetabolic syndromebody mass indexBMIfatty liver indexHepatic fibrosislow density lipoproteinsLDLvery low-density lipoproteinshigh density lipoproteinsMETSestimated glomerular filtration rateNash chylomicronsGamma-glutamyltransferase
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Karlijn J. Nass, Eline H. van den Berg, Klaas Nico Faber, Tim C.M.A. Schreuder, Hans Blokzijl, Robin P.F. Dullaart,